After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Ironwood Pharmaceuticals Inc is $180.30M. A total of 0.65 million shares were traded on the day, compared to an average of 1.74M shares.
In the most recent transaction, Gaskins Tammi L sold 1,316 shares of IRWD for 0.84 per share on Aug 11 ’25. After the transaction, the Chief Commercial Officer now owns 241,280 company shares. In a previous transaction on Aug 11 ’25, John Minardo sold 7,754 shares at 0.84 per share. IRWD shares that Chief Legal Officer owns now total 400,378.
Among the insiders who sold shares, Martini Gregory S. disposed of 1,265 shares on Aug 11 ’25 at a per-share price of $0.84. This resulted in the Chief Financial Officer holding 182,545 shares of IRWD after the transaction. In another insider transaction, Silver Ronald sold 2,846 shares at $0.84 per share on Aug 11 ’25. Company shares held by the Principal Accounting Officer now total 276,809.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, IRWD has a high of $5.13 and a low of $0.53.
As of this writing, IRWD has an earnings estimate of $0.09 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.09 per share and a lower estimate of $0.09. The company reported an EPS of $0.02 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. IRWD’s latest balance sheet shows that the firm has $620.13M in Cash & Short Term Investments as of fiscal 2021. There were $475.80M in debt and $161.70M in liabilities at the time. Its Book Value Per Share was -$1.90, while its Total Shareholder’s Equity was $605.91M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRWD is Buy with a score of 3.00.
